Quest Diagnostics — PathAI software and algorithm licensing (2024)
Quest will license AISight and PathAI algorithms for U.S. pathology operations. The licensing agreements are separate from Quest's acquisition of selected laboratory assets.
- Announced
- 1 May 2024 1
Contract facts
Source per value- DateDate the contract, order or partnership was announced or agreed, as stated in the cited source (YYYY-MM-DD). Empty when the source gives only a month or a year.
- 2024-05-011
- BuyerThe purchasing organisation or named customer.
- Quest Diagnostics1
- VendorThe contracting supplier or AI provider, as named in the source.
- PathAI1
- SectorGovernment for public-sector buyers (defence, intelligence, civil agencies, health services); Enterprise for companies.
- Enterprise
- Product or programThe AI product, model, platform or program supplied.
- AISight1
- Contract typeThe vehicle as the source names it: IDIQ, task order, other transaction agreement, blanket purchase agreement, enterprise agreement.
- Software and algorithm licensing agreements1
- Delivery locationWhere the service is delivered, when the source says.
- United States1
Sources
- pathai.com accessed 2026-11-11
Dollar figures are stated in the source’s own currency and are not converted. Read the summary for what a figure covers.
Related contracts
All 87 contracts-
Moderna — OpenAI enterprise collaboration (2024)
Moderna · OpenAI
Undisclosed -
Eli Lilly — Isomorphic Labs AI discovery collaboration (2024)
Eli Lilly and Company · Isomorphic Labs
Undisclosed -
Novartis — Isomorphic Labs AI discovery collaboration (2024)
Novartis · Isomorphic Labs
Undisclosed -
Boehringer Ingelheim — IBM antibody discovery agreement (2023)
Boehringer Ingelheim · IBM
Undisclosed -
Mayo Clinic — Abridge enterprise clinical documentation agreement (2025)
Mayo Clinic · Abridge
Undisclosed
Spot a change?
Amendment, renewal or a figure that moved? Email hello@aicontractstracker.com with the source link and we update this row and its verified date.